To The Moon

$Ondas Holdings Inc.(ONDS)$ keep calm n carry on

$TIGR 20250815 13.0 CALL$  Yeah. Get some gains[Lovely]  

$Grab Holdings(GRAB)$ 46 x calls will be taken away finally after months. Give me back my usd.

$UnitedHealth(UNH)$   [Cry]  [Cry]  [Cry]  few more dollars to break even

$PLTR 20250822 170.0 PUT$ close for profit. only held for 1 week, contract closed at TP. Small win.

$UNH 20250919 300.0 CALL$  Yeah, I love you $UNH 

$GRAB 20250822 5.5 CALL$ will this be changed? let see it on next week. 

$Grab Holdings(GRAB)$ finally stays above $5 after earnings. A tough options night where many are red.  Hold on tight as it moves above $5 and slowly into $5.30 in Aug. Good luck.

$Sea Ltd(SE)$  the bull is running

$HIMS 20250822 48.0 PUT$ 2nd assignment of the month...12straight down session after earning completed before...really capital intensive lol Hopefully Santa rally help me liquidate with profit soon

$NIO Inc.(NIO)$  keeping my conviction is profitable 

‌$Roblox Corporation(RBLX)$  ‌Roblox’s options are seeing elevated volatility driven by conflicting catalysts—bullish AI/metaverse bets vs. regulatory risks and valuation concerns. Key strikes at $120 (call-heavy) and $100 (put protection) dominate activity. Key Drivers of Options Movement: Near-Term Catalysts : S&P Credit Upgrade (Aug 14) : Upgraded to BBB- with "Positive" outlook, sparking call buying (Aug 16 $125C open interest surged 48%) 15. Child Safety Lawsuit Risk: Louisiana AG lawsuit (23) drove put volume at $95-$100 strikes (put/call ratio spiked to 1.2x on Aug 16). Volatility & Positioning : IV Rank: Current implied volatility 65% (vs. 30-day avg of 58%), pricing in ±12% move by Aug 23 expiry. Open Interest Skew: Max pain at

Intel Options Explode and $25 Calls Surge Amid Possible US Stake in Company Fueled by reports of Trump administration talks to take stake in, $Intel(INTC)$   shares surged 23% last week. Options volume hit a 6-month high, with aggressive call buying dominating sentiment. Options Data Analysis Volatility & Sentiment Signals: ~Implied Volatility (IV): 60.13%, Sitting at 64th percentile of 1-year range. ~Put Skew: Plunged from +6 in April to -7.9, signaling reduced demand for downside protection. Open Interest: The Put/Call ratio stands at 0.59, indicating a dominance of call options. Notably, open interest is heavily concentrated in the $25 strike call options expiring on September 19, 2025. Max Open Interest

TSMC Arizona Posts First Positive Equity-Method Contribution: What's Driving It and What Could Derail It What happened $Taiwan Semiconductor Manufacturing(TSM)$  quietly crossed a milestone in Q2: its Arizona subsidiary showed a positive 'share of profits of investee' in the company's consolidated filing. By contrast, JASM (Kumamoto) remained in the red, underscoring a faster profitability turn in the U.S. asset than in Japan at this stage of ramp. By the numbers ~Node mix: In Q2, 5-nanometer technologies contributed 36% of wafer revenue; N4/N4P/N4X are classified by TSMC as part of the 5-nanometer family, so Arizona's N4 output is inside that bucket. ~Arizona status: U.S. Commerce said 4-nm production in Phoenix

$Dover(DOV)$ I added to my position in Dover (DOV) following its solid Q2 2025 results, where adjusted EPS of $2.44 beat expectations and revenue grew 5% to $2.05 billion. While much of the top-line gain came from acquisitions and currency, margin improvements and strong cash flow highlight operational efficiency. Importantly, management raised full-year adjusted EPS guidance to $9.35–$9.55, signaling confidence despite macro uncertainties. With a diversified industrial portfolio and disciplined execution, Dover continues to demonstrate resilience, making it a compelling addition to my holdings at this stage.

$Apple(AAPL)$ I added to my Apple (AAPL) position following Morgan Stanley’s bullish iPhone forecast upgrade, now expecting 54M units in the September quarter versus 50M previously. The revision reflects pent-up replacement demand, stronger designs, and margin improvements. Importantly, peak tariff concerns have eased while regulatory impacts remain softer than feared. With services pricing yet to be adjusted in two years, Apple holds untapped growth potential. Valuation relative to the S&P 500 remains fair, and upward estimate revisions historically drive multiple expansion, strengthening my conviction in Apple’s sustained growth trajectory.

$SMMT 20250822 25.0 PUT$ 我看好賣出SMMT $25認沽期權的策略，即便被行權接貨，安全邊際依然極高。從基本面看，SMMT專注於開發ivonescimab（雙特異性抗體），在非小細胞肺癌（NSCLC）治療中展現競爭力。2025年Q1財報顯示，現金及短期投資達3.613億美元，無重大長期債務，財務穩健（流動資產為短期負債的2.13倍）。儘管Q1淨虧損6290萬美元（每股-0.09美元），但其臨床進展亮眼：HARMONi-6試驗顯示ivonescimab聯合化療在NSCLC中進展自由存活期（PFS）顯著優於對照組，獲中國NMPA批准，潛在峰值年收入達100億美元。產品競爭力獲市場認可，與阿斯利康洽談150億美元授權交易進一步提升估值空間。 從估值角度，SMMT當前股價26.29美元（截至2025年8月18日），市淨率（P/B）約為高位，但DCF模型估計內在價值遠超當前價格（WallStreetZen估計合理價值僅0.18美元，但分析師平均目標價34.73美元，潛在上漲64.6%）。技術分析顯示，$25為一年內關鍵支撐位（52周低點2.10美元，高點36.91美元），近期RSI（57.33）處中性，CCI（11.65）未超買，短期波動後反彈概率高。行業趨勢方面，生物科技與免疫療法市場2025-2030年預計CAGR超10%，SMMT的全球試驗與合作強化其領先地位。 即便期權被行權，$25的接貨價遠低於分析師目標價（最高44美元），結合穩健現金流與臨床催化劑，風險可控，長期獲利空間廣闊。此策略兼具防守性（低估值支撐）與進攻性（臨床與合作催化），安全邊際顯著。

$FIG 20250829 65.0 PUT$ Figma財務表現亮眼，2024財年（截至2025年1月）營收7.49億美元，同比增長48%，LTM營收超8.2億美元。2025財年Q1實現4490萬美元淨利，展現“增長+盈利”雙贏。账面現金超15億美元，幾無長期債務，包括Adobe支付的10億美元解約金，為AI投資與平台建設提供資金支持。Figma開創雲端SaaS+實時協作模式，解決傳統設計軟件痛點，採用“增值免費”策略，吸引1300萬註冊用戶，2024財年毛利率達91%。其插件與模板生態增強用戶粘性。儘管AI浪潮帶來依賴第三方模型、數據合規及同質化競爭風險，Figma積極布局AI，長期成長潛力巨大。當前股價下跌或為短期波動，未來前景依然樂觀。我沽出認沽期權做好。

$MSTR STRADDLE 250919 CALL 320.0/PUT 320.0$ share for coins